Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 11, 2009, Pages 1799-1804

  Lin, Aiwu ^a   Qian, Jiaqi ^a   Li, Xiaomei ^b   Yu, Xueqing ^c   Liu, Wenhu ^d   Sun, Yang ^e   Chen, Nan ^f   Mei, Changlin ^g  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; GLUCOSE; ICODEXTRIN; NITROGEN; PERITONEAL DIALYSIS FLUID; UREA;

ADULT; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSATE; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ULTRAFILTRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73549124091     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02950509     Document Type: Article

References (20)

1. Fang W, Qian JQ, Lin AW, Rowaie F, Ni ZH, Yao Q, Bargman JM, Oreopoulos DG: Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant 1-8, 2008
2. Chung SH, Heimburger O, Lindholm B, Lee HB: Peritoneal dialysis patient survival: A comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 20: 1207-1213, 2005
3. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292, 1998
4. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S, Krediet R, Lindholm B, Oreopoulos D, Rippe B, Selgas R: Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 20[Suppl 4]: S5-S21, 2000
5. Wolfson M, Piraino B, Hamburger RJ, Morton AR; Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 40: 1055-1065, 2002
6. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S: Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 16: 546-554, 2005
7. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM: Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 14: 1530-1535, 1999
8. Wilkie ME, Plant MJ, Edwards L, Brown CB: Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival. Perit Dial Int 17: 84-87, 1997
9. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K: Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrology 2: 2, 2001
10. Twardowski ZJ: Peritoneal equilibration test. Perit Dial Bull 7: 138-147, 1987
11. Nakamoto H, Babazono T, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Yorioka N, Sato M, Yamabe K, Kawaguchi Y: Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 21: 168-174, 2005
12. Hiramatsu T, Furuta S, Kakuta H: Favorable changes in lipid metabolism and cardiovascular parameters after icodextrin use in peritoneal dialysis patients. Adv Perit Dial 23: 58-61, 2007
13. Furuya R, Odamaki M, Kumagai H, Hishida A: Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant 21: 494-498, 2006
14. Hwang JC, Wang HY, Wang CT, Chen HC: Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions. J Nephrol 19: 758-763, 2006
15. Araújo Teixeira MR, Pecoits-Filho RF, Romão Junior JE, Sabbaga E, Marcondes MM, Abensur H: The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 22: 229-233, 2002
16. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimbürger O, Lindholm B, Nordfors L, Robert A, Devuyst O: Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 67: 2477-2487, 2005
17. Jiang N, Qian JQ, Lin AW, Lindholm B, Axelsson J, Yao Q: Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26: 423-428, 2008
18. Gokal R, Moberly J, Lindholm B, Mujais S: Metabolic and laboratory effects of icodextrin. Kidney Int 61[suppl 81]: S62-S71, 2002
19. Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R: Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 21: 275-281, 2001
20. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi Y. Japanese Extraneal Collaborated Study Group. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 27: 409-415, 2007